FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q38958765> ?p ?o ?g. }

• Q38958765 description "2014 nî lūn-bûn" @default.
• Q38958765 description "2014年の論文" @default.
• Q38958765 description "2014年論文" @default.
• Q38958765 description "2014年論文" @default.
• Q38958765 description "2014年論文" @default.
• Q38958765 description "2014年論文" @default.
• Q38958765 description "2014年論文" @default.
• Q38958765 description "2014年论文" @default.
• Q38958765 description "2014年论文" @default.
• Q38958765 description "2014年论文" @default.
• Q38958765 description "2014年论文" @default.
• Q38958765 description "2014年论文" @default.
• Q38958765 description "2014年论文" @default.
• Q38958765 description "2014년 논문" @default.
• Q38958765 description "article científic" @default.
• Q38958765 description "article scientific" @default.
• Q38958765 description "article scientifique" @default.
• Q38958765 description "articol științific" @default.
• Q38958765 description "articolo scientifico" @default.
• Q38958765 description "artigo científico" @default.
• Q38958765 description "artigo científico" @default.
• Q38958765 description "artigo científico" @default.
• Q38958765 description "artikel ilmiah" @default.
• Q38958765 description "artikull shkencor" @default.
• Q38958765 description "artikulong pang-agham" @default.
• Q38958765 description "artykuł naukowy" @default.
• Q38958765 description "artículo científico publicado en 2014" @default.
• Q38958765 description "artículu científicu espublizáu en 2014" @default.
• Q38958765 description "bilimsel makale" @default.
• Q38958765 description "bài báo khoa học" @default.
• Q38958765 description "naučni članak" @default.
• Q38958765 description "scienca artikolo" @default.
• Q38958765 description "scientific article published on October 2014" @default.
• Q38958765 description "scientific article published on October 2014" @default.
• Q38958765 description "scientific article published on October 2014" @default.
• Q38958765 description "teaduslik artikkel" @default.
• Q38958765 description "tieteellinen artikkeli" @default.
• Q38958765 description "tudományos cikk" @default.
• Q38958765 description "vedecký článok" @default.
• Q38958765 description "vetenskaplig artikel" @default.
• Q38958765 description "videnskabelig artikel" @default.
• Q38958765 description "vitenskapelig artikkel" @default.
• Q38958765 description "vitskapeleg artikkel" @default.
• Q38958765 description "vědecký článek" @default.
• Q38958765 description "wetenschappelijk artikel" @default.
• Q38958765 description "wissenschaftlicher Artikel" @default.
• Q38958765 description "επιστημονικό άρθρο" @default.
• Q38958765 description "мақолаи илмӣ" @default.
• Q38958765 description "наукова стаття, опублікована в жовтні 2014" @default.
• Q38958765 description "научна статия" @default.
• Q38958765 description "научная статья" @default.
• Q38958765 description "научни чланак" @default.
• Q38958765 description "научни чланак" @default.
• Q38958765 description "מאמר מדעי" @default.
• Q38958765 description "مقالة علمية نشرت في أكتوبر 2014" @default.
• Q38958765 description "অক্টোবর ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q38958765 description "บทความทางวิทยาศาสตร์" @default.
• Q38958765 description "სამეცნიერო სტატია" @default.
• Q38958765 name "Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells" @default.
• Q38958765 name "Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells" @default.
• Q38958765 name "Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells" @default.
• Q38958765 type Item @default.
• Q38958765 label "Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells" @default.
• Q38958765 label "Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells" @default.
• Q38958765 label "Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells" @default.
• Q38958765 prefLabel "Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells" @default.
• Q38958765 prefLabel "Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells" @default.
• Q38958765 prefLabel "Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells" @default.
• Q38958765 P1433 Q38958765-886F777C-8242-4211-94E1-22C3C8827084 @default.
• Q38958765 P1476 Q38958765-5767192C-951C-40D4-933E-82759D73E495 @default.
• Q38958765 P2093 Q38958765-28FD98D4-6E2A-4F03-967D-5A5A2A4CF550 @default.
• Q38958765 P2093 Q38958765-36ED9FAA-B786-481B-95D2-07936E19840B @default.
• Q38958765 P2093 Q38958765-5817E077-8042-49D8-87D7-C4335913D6CA @default.
• Q38958765 P2093 Q38958765-908FE01F-1230-4DAA-91FF-B289B218C0F0 @default.
• Q38958765 P2093 Q38958765-9A160319-5FBD-4879-9BA1-0D0128CBAC02 @default.
• Q38958765 P2093 Q38958765-A3404A22-9963-4225-986F-524435632687 @default.
• Q38958765 P2093 Q38958765-AA8227F5-ACDB-42E8-8522-3C11CCC67169 @default.
• Q38958765 P2093 Q38958765-AC088FD9-0321-4BD8-B3C3-017E3A862CBE @default.
• Q38958765 P2093 Q38958765-B7492826-4709-426A-B775-246F7EBAAC75 @default.
• Q38958765 P2093 Q38958765-D39CB2C3-627A-4D75-B627-622D9B5E6ABF @default.
• Q38958765 P2093 Q38958765-DC76C9B9-2968-4AD4-955A-06B0BD6EDFD4 @default.
• Q38958765 P2093 Q38958765-F7D22DE2-6A55-4A26-8463-95BF198D9B0A @default.
• Q38958765 P304 Q38958765-C99228ED-0F85-4EDD-8152-217752A5FB72 @default.
• Q38958765 P31 Q38958765-DF2BA81C-60C1-4E72-A008-BAC2E07639AE @default.
• Q38958765 P356 Q38958765-2799BF1B-ED70-4C74-823B-65A8D2DC1745 @default.
• Q38958765 P433 Q38958765-01EB8082-CEF0-4CFA-979B-7E3A57CDCCA0 @default.
• Q38958765 P478 Q38958765-FD6C4C3B-096A-495D-A1CD-FFCDC8041465 @default.
• Q38958765 P577 Q38958765-216E8BB7-881F-46E3-9BA1-2D0DE0358611 @default.
• Q38958765 P5875 Q38958765-38FC9008-FB68-4DF3-993B-F54E3CC2637A @default.
• Q38958765 P698 Q38958765-1D375799-20C5-4AF1-861A-C6CF84C55ED2 @default.
• Q38958765 P921 Q38958765-0DA770B9-987F-4000-885E-055302BFC284 @default.
• Q38958765 P356 OR.2014.3331 @default.
• Q38958765 P698 25198583 @default.
• Q38958765 P1433 Q7092098 @default.
• Q38958765 P1476 "Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells" @default.
• Q38958765 P2093 "Dandan Yuan" @default.
• Q38958765 P2093 "Feng Bi" @default.
• Q38958765 P2093 "Hongwei Xia" @default.
• Q38958765 P2093 "Liang Chen" @default.
• Q38958765 P2093 "Qi Chen" @default.

• next